Blood Centers of America
Blood Centers of America (BCA) is the largest blood supply network in the United States, comprising over 60 independent community blood centers that collectively distribute approximately 50% of the nation's blood supply. BCA supports member organizations through supply chain solutions, donor recruitment, advocacy, disaster response, and purchasing power. In addition to providing whole blood, red blood cells, platelets, plasma, cells, and tissues for therapeutic, diagnostic, research, and advanced therapy applications, BCA and its network are engaged in the development and delivery of advanced therapies including cell and gene therapy starting materials, processing, and manufacturing. BCA actively mobilizes resources in response to national emergencies, pandemics, and technological advances in donor experience and biotherapeutics.
Industries
N/A
Nr. of Employees
small (1-50)
Blood Centers of America
1300 Division Road, Suite 102, West Warwick, Rhode Island 02893
Products
Whole blood and red blood cells
Supply of whole blood units and separated red blood cell products for transfusion and research.
Platelets
Provision of platelet products, including pathogen-reduced units, for transfusion and research.
Plasma and cryoprecipitate
Distribution of plasma and cryoprecipitate for therapeutic, clinical, or research use.
Convalescent plasma
Collection and distribution of convalescent plasma containing antibodies from recovered patients for therapeutic use, especially in response to COVID-19.
Cells for therapy and research
Supply and processing of various human cell types for use in advanced therapies and biomedical research.
Tissues for regenerative medicine
Supply of human tissues for use in regenerative medicine, transplantation, and research.
Whole blood and red blood cells
Supply of whole blood units and separated red blood cell products for transfusion and research.
Platelets
Provision of platelet products, including pathogen-reduced units, for transfusion and research.
Plasma and cryoprecipitate
Distribution of plasma and cryoprecipitate for therapeutic, clinical, or research use.
Convalescent plasma
Collection and distribution of convalescent plasma containing antibodies from recovered patients for therapeutic use, especially in response to COVID-19.
Cells for therapy and research
Supply and processing of various human cell types for use in advanced therapies and biomedical research.
Tissues for regenerative medicine
Supply of human tissues for use in regenerative medicine, transplantation, and research.
Expertise Areas
- Blood banking and transfusion medicine
- Advanced therapies and regenerative medicine
- Cell therapy and cell sourcing
- Plasma and tissue collection and distribution
Key Technologies
- Cell therapy collection and processing
- Pathogen reduction technology
- Molecular testing for blood safety
- Blood establishment computer systems (BECS)
News & Updates
Seven blood centers from five states founded the Blood Emergency Readiness Corps for rapid response to emergencies.
LifeShare launches a biologics division to expand delivery of cellular products.
National FDA approval for COVID-19 convalescent plasma distribution for immunocompromised patients.
Hoxworth Blood Center and Local 12 earned international recognition for their partnership.
Explores how new technologies can help attract younger blood donors and maintain a stable blood supply.
National Geographic covers efforts to keep Zika virus out of the US blood supply.
Seven blood centers from five states founded the Blood Emergency Readiness Corps for rapid response to emergencies.
LifeShare launches a biologics division to expand delivery of cellular products.
National FDA approval for COVID-19 convalescent plasma distribution for immunocompromised patients.
Hoxworth Blood Center and Local 12 earned international recognition for their partnership.
Explores how new technologies can help attract younger blood donors and maintain a stable blood supply.
National Geographic covers efforts to keep Zika virus out of the US blood supply.